Pfizer Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/05/2025 ,inter alia, to consider and approve This is to inform that a meeting of ....
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pfizer Ltd has informed the stock exchanges that its Board of Directors will meet on Monday, May 19, 2025. The main agenda is to consider, approve and take on record the audited financial results for the quarter and financial year ended March 31, 2025. The Board will also consider the recommendation of a dividend, if any, for FY 2024-25. The trading window for dealing in the company's shares has been closed from March 31, 2025 (close of business) and will remain closed until 48 hours after the results are made public on May 19, 2025. This is a standard pre-results intimation filed under SEBI Listing Regulations and does not contain any actual financial numbers.
No immediate impact on the stock as no results or numbers have been disclosed yet. Investors should watch the May 19 announcement closely for FY25 earnings and any dividend declaration, which could drive short-term price movement.